Patent Settlement Agreements In Pharma: EC’s Preliminary View on Teva/Cephalon

Anticompetitive Practices, ReandaBlogLeave a comment

On 17 July 2017 the European Commission (EC) sent Statement of Objections to pharmaceutical company Teva with its preliminary view that a patent settlement agreement concluded with Cephalon was in breach of EU competition law. Under the agreement, Teva committed not to market a cheaper generic version of Cephalon’s drug for sleep disorders, modafinil. In…

EC vs Turkey in Compliance With WTO Rules: Dumping Exports To The EU and Restricting Imports from The EU?

International Trade, ReandaBlogLeave a comment

1. Introduction The European Commission (“Commission”), being quiet active between the last week of June and first week of July 2017, initiated trade remedy investigations (i.e. anti-dumping and expiry review) against various countries, including Turkey. In particular, the Commission launched an anti-dumping investigation concerning Turkey’s exports to the EU and a trade barrier examination concerning…